Background Keloids are pathologic scars that pose a significant functional and cosmetic
burden. They are challenging to treat, despite the multitude of treatment modalities currently …

Updated International Clinical Recommendations on Scar Manag... : Dermatologic Surgery
Updated International Clinical Recommendations on Scar Management: Part 1—Evaluating …

Since their earliest description, keloids and hypertrophic scars have beleaguered patients
and clinicians alike. These scars can be aesthetically disfiguring, functionally debilitating …

Background: There is no uniform treatment for pathological scars, including keloids and
hypertrophic scars, in clinic currently. Previously, multiple randomized controlled trials have …

Abstract In the 1990s, 5-fluorouracil (5-FU) was introduced as a treatment for keloids;
however, there is still no consensus on its use. In order to guide clinical practice, a …

Cutaneous dermal injury inevitably leads to scar formation. 1 The reparative process
involves inflammation, granulation tissue formation, and matrix remodeling, which can result …

Vesicles that are specifically designed to overcome the stratum corneum barrier in intact skin
provide an efficient transdermal (systemic or local) drug delivery system. They can be …

Hypertrophic (HTSs) and keloid scars are common dermatological complaints produced by
disruption of the normal wound-healing process. Despite a wide array of therapeutic options …

Keloid disease (KD) is a common, benign, dermal fibroproliferative growth of unknown
aetiology. Lesions tend to grow over time; they often recur following therapy and do not …

Background Keloid disease treatment continues to be unsatisfactory with high recurrence
rates. We evaluated the literature regarding the effectiveness of keloid excision with various …